PT100902A - Derivados de mupirocina, uteis como agentes antibacterianos e antimicoplasmaticos,e processo para a sua preparacao - Google Patents

Derivados de mupirocina, uteis como agentes antibacterianos e antimicoplasmaticos,e processo para a sua preparacao

Info

Publication number
PT100902A
PT100902A PT100902A PT10090292A PT100902A PT 100902 A PT100902 A PT 100902A PT 100902 A PT100902 A PT 100902A PT 10090292 A PT10090292 A PT 10090292A PT 100902 A PT100902 A PT 100902A
Authority
PT
Portugal
Prior art keywords
antimicoplasmatic
uteis
mupirocin
antibacterial
derivatives
Prior art date
Application number
PT100902A
Other languages
English (en)
Inventor
Nigel John Perryman Broom
Peter John O'hanlon
John Stephen Elder
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919120491A external-priority patent/GB9120491D0/en
Priority claimed from GB929201507A external-priority patent/GB9201507D0/en
Priority claimed from GB929219053A external-priority patent/GB9219053D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PT100902A publication Critical patent/PT100902A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT100902A 1991-09-26 1992-09-24 Derivados de mupirocina, uteis como agentes antibacterianos e antimicoplasmaticos,e processo para a sua preparacao PT100902A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919120491A GB9120491D0 (en) 1991-09-26 1991-09-26 Novel compounds
GB929201507A GB9201507D0 (en) 1992-01-24 1992-01-24 Novel compounds
GB929219053A GB9219053D0 (en) 1992-09-09 1992-09-09 Novel compounds

Publications (1)

Publication Number Publication Date
PT100902A true PT100902A (pt) 1993-11-30

Family

ID=27265863

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100902A PT100902A (pt) 1991-09-26 1992-09-24 Derivados de mupirocina, uteis como agentes antibacterianos e antimicoplasmaticos,e processo para a sua preparacao

Country Status (6)

Country Link
EP (1) EP0605524A1 (pt)
JP (1) JPH06510781A (pt)
AU (1) AU2594092A (pt)
MX (1) MX9205457A (pt)
PT (1) PT100902A (pt)
WO (1) WO1993006118A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320594D0 (en) * 1993-10-06 1993-11-24 Zeneca Ltd Heterocyclic compounds
US6534037B1 (en) 1998-01-21 2003-03-18 Neorx Corporation Non-steroidal compounds for steroid receptors and uses relating thereto
US6291514B1 (en) 1998-02-09 2001-09-18 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
US7649098B2 (en) 2006-02-24 2010-01-19 Lexicon Pharmaceuticals, Inc. Imidazole-based compounds, compositions comprising them and methods of their use
TW200920355A (en) 2007-09-06 2009-05-16 Lexicon Pharmaceuticals Inc Compositions and methods for treating immunological and inflammatory diseases and disorders
JP6116782B1 (ja) * 2015-08-28 2017-04-19 積水メディカル株式会社 ベンジル化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0090603A3 (en) * 1982-03-25 1984-05-16 Beecham Group Plc Antibacterial compounds

Also Published As

Publication number Publication date
MX9205457A (es) 1993-03-01
AU2594092A (en) 1993-04-27
JPH06510781A (ja) 1994-12-01
EP0605524A1 (en) 1994-07-13
WO1993006118A1 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
PT1124810E (pt) Derivados 2-amino-tiazole, processo para a sua preparacao e sua utilizacao como agentes anti-tumorais
BR9506147A (pt) Novos derivados de eritromicina seu processo de preparação e sua aplicação como medicamentos
BR9306629A (pt) Processo para preparar derivados de triaza-ciclo-nonano
BR9911123B1 (pt) compostos derivados de diàxido de benzotiepina-1,1, processo para sua preparaÇço e seu uso, medicamentos contendo-os e processo para a preparaÇço desses.
BR9408463A (pt) Novos derivados de ginkgolide e processo para sua preparação
BR9205458A (pt) Novos compostos A83543 e processo para a produção dos mesmos.
PT94059A (pt) Processo para a preparacao de copolimetros hidrossoluveis, de n-vinilamidas
PT100917A (pt) Heteroarilaminas que actuam como novos inibidores de acetilcolinesterase e processo para a sua preparacao
PT99984A (pt) Processo para a preparacao de compostos 1-carba-(1-destia) cefem uteis como agentes antibacterianos
BR9300203A (pt) Embalagem feita de embalagens parciais,assim como o processo e o dispositivo para sua fabricacao
BR9001989A (pt) Composicao de polipropileno e processo para fabricar a mesma
PT94045A (pt) Processo para a preparacao de derivados de 2-piperidino-1-alcanol uteis como agentes anti-isquemicos
BR9202325A (pt) Composto,processo para a sua preparacao,preparado farmaceutico e processo para a sua preparacao
BR9305161A (pt) Composto, composição farmacêutica e processo para a preparação do composto
BR9300732A (pt) Derivada de triazol,inseticida e processo para produzir um derivado de triazol
PT1015421E (pt) Novos derivados de fenilamidina processo para a sua preparacao e sua utilizacao como medicamentos
BR9305115A (pt) Processo para fabricaçáo de produtos, particularmente artigos de fumo
PT1015433E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua producao e sua utilizacao como medicamentos
BR9006845A (pt) Derivado de bicicloheptadiona substituido,processo para preparacao de um composto e herbicida
BR9002805A (pt) Derivados de 2-acilamino-4-halogeno-5-nitrotiazol,processo para a sua preparacao,sua aplicacao,composicao praguicida,processo para sua preparacao,processo para combater pragas,derivados de 4-halogeno-2-halogenocarbonilamino-5-nitrotiazol,processo para sua preparacao e sua aplicacao
BR8904468A (pt) Composicao,processo para a preparacao de produtos e aplicacao
PT906326E (pt) Novos derivados aromaticos substituidos por ribose processo para a sua preparacao e sua utilizacao como medicamentos
PT88254A (pt) Processo para a preparacao de derivados de eritromicina a modificada em c.12
PT1053224E (pt) Bifenilsulfonilcianamida, processo para a sua preparacao e sua utilizacao como medicamento
PT1157020E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua preparacao e sua utilizacao como medicamentos

Legal Events

Date Code Title Description
FC3A Refusal

Effective date: 19990302